drugset / Trial / NCT00147719

WelChol® With Metformin in Treating Patients With Type 2 Diabetes

NCT00147719

Phase 3 Completed 300 enrolled Daiichi Sankyo
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to see how safe and effective and tolerable the use of colesevelam hydrochloride is for type 2 diabetes when added to metformin alone or in combination with other anti-diabetic drugs.

Timeline

Start
2004-06
Primary completion
2006-07
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Colesevelam Other / unclassified 3.75 g